PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,023.50
Bid: 1,024.50
Ask: 1,025.00
Change: -1.50 (-0.15%)
Spread: 0.50 (0.049%)
Open: 1,023.50
High: 1,027.50
Low: 1,019.50
Prev. Close: 1,025.00
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

11 Mar 2022 18:19

RNS Number : 5721E
Smith & Nephew Plc
11 March 2022
 

11 March 2022

Smith & Nephew plc

Transaction in Own Shares

Smith & Nephew plc (the "Company") announces today it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $125 million share buyback programme announced on 22 February 2022 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 14 April 2021.

 

Aggregated details of share purchase transactions according to trading venue are set out below:

 

Date of transaction:

Venue:

Number of ordinary shares repurchased:

Highest price paid per ordinary share (GBP):

Lowest price paid per ordinary share (GBP):

Volume weighted average price paid per ordinary share (GBP):

11/03/2022

XLON

512,951

£12.2500

£11.9100

£12.0869

11/03/2022

BATE

0

£0.00

£0.00

£0.00

11/03/2022

CHIX

0

£0.00

£0.00

£0.00

 

The Company intends to hold these shares in Treasury and then cancel them.

Since 23 February 2022, the Company has purchased 2,979,447 shares at a cost (including dealing and associated costs) of £36,658,491.48.

 

Following the purchase of these shares, the Company holds 8,237,648 of its shares in Treasury. The Company's issued share capital, with one voting right per share consists of 876,999,645 ordinary shares of US20¢ each (excluding treasury shares). This figure of 876,999,645 is the figure which should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of LR 12.4.6.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a full breakdown of the individual purchases is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/5721E_1-2022-3-11.pdf

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFAFAFEESEFD
Date   Source Headline
26th Mar 20203:23 pmRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20204:38 pmRNSPrice Monitoring Extension
10th Mar 20205:32 pmRNSDirector/PDMR Shareholding
9th Mar 20205:06 pmRNSDirector/PDMR Shareholding
5th Mar 202012:55 pmRNSHolding(s) in Company
5th Mar 20207:01 amRNSDirectorate Change
5th Mar 20207:00 amRNSDirectorate Change
2nd Mar 20205:00 pmRNSAnnual Financial Report
2nd Mar 20203:46 pmRNSTransaction in Own Shares
2nd Mar 20201:46 pmRNSTotal Voting Rights
25th Feb 20206:20 pmRNSTransaction in Own Shares
24th Feb 20205:52 pmRNSTransaction in Own Shares
24th Feb 202011:12 amRNSDirector/PDMR Shareholding
21st Feb 20204:11 pmRNSDirector/PDMR Shareholding
21st Feb 202010:48 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
7th Feb 20203:10 pmRNSDirector/PDMR Shareholding
6th Feb 20208:24 amRNSDirector Declaration
3rd Feb 20202:25 pmRNSBlock listing Interim Review
3rd Feb 202011:24 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSSmith+Nephew acquires Tusker Medical, Inc.
21st Jan 20203:00 pmRNSNotice of Results
16th Jan 20203:56 pmRNSDirector/PDMR Shareholding
2nd Jan 202010:34 amRNSTotal Voting Rights
2nd Dec 20194:34 pmRNSAdditional Listing
2nd Dec 201912:13 pmRNSTotal Voting Rights
20th Nov 20199:17 amRNSDirector/PDMR Shareholding
14th Nov 20199:17 amRNSDirector/PDMR Shareholding
12th Nov 20194:21 pmRNSTransaction in Own Shares
8th Nov 201912:54 pmRNSTransaction in Own Shares
8th Nov 20199:07 amRNSDirector/PDMR Shareholding
7th Nov 20195:33 pmRNSTransaction in Own Shares
6th Nov 20195:56 pmRNSTransaction in Own Shares
6th Nov 20193:05 pmRNSDirector/PDMR Shareholding
5th Nov 20196:13 pmRNSTransaction in Own Shares
4th Nov 20191:07 pmRNSDirector Declaration
4th Nov 201911:50 amRNSTransaction in Own Shares
1st Nov 20191:24 pmRNSDirector/PDMR Shareholding
1st Nov 201910:53 amRNSTotal Voting Rights
31st Oct 20194:43 pmRNSDirector/PDMR Shareholding
31st Oct 201911:21 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSTrading Statement
21st Oct 20197:00 amRNSDirectorate Change
18th Oct 20199:17 amRNSDividend Declaration
15th Oct 20191:14 pmRNSNotification of Major Holdings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.